Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sean A. Mccarthy

CEO at CytomX Therapeutics, Inc. (CTMX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 16 NewSEC CTMXCytomX Therapeutics, Inc. Sell Plan 101,7931,089,684 held (−9%) $4.54 $462K -49.8%
Mar 19SEC CTMXCytomX Therapeutics, Inc. Sell Plan 118,9691,078,922 held (−10%) $6.42 $764K -64.5%
Nov 10SEC CTMXCytomX Therapeutics, Inc. Sell Plan 101,793987,891 held (−9%) $4.54 $462K -49.8%
  • Sell

    CEO Sean A. Mccarthy sold $462K of CTMX at $4.54 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Sean A. Mccarthy sold $764K of CTMX at $6.42 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Sean A. Mccarthy sold $462K of CTMX at $4.54 — pre-scheduled 10b5-1 plan sale.